Global Anterior Uveitis Treatment Market by Treatment Type (Anti-Tumor Necrosis Factor Agents, Corticosteroids, Cycloplegic Agents), Distribution Channel - Forecast 2024-2030

Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "Global Anterior Uveitis Treatment Market by Treatment Type (Anti-Tumor Necrosis Factor Agents, Corticosteroids, Cycloplegic Agents), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Forecast 2024-2030" report has been added to * ResearchAndMarkets.com's* offering.

The Anterior Uveitis Treatment Market size was estimated at USD 255.63 million in 2023, USD 277.28 million in 2024, and is expected to grow at a CAGR of 8.56% to reach USD 454.31 million by 2030.

*Market Share Analysis*

By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we offer companies a greater understanding of their performance and the challenges they face when competing for market share.

Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

*Market Segmentation & Coverage*

This research report categorizes the Anterior Uveitis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

· Treatment Type

· Anti-Tumor Necrosis Factor Agents
· Corticosteroids
· Cycloplegic Agents
· Immunosuppressants
· Distribution Channel

· Hospital Pharmacies
· Online Pharmacies
· Retail Pharmacies

*Companies Mentioned*

· AbbVie Inc.
· Aciont Inc.
· Ajanta Pharma Ltd
· Aldeyra Therapeutics, Inc.
· Alimera Sciences Inc.
· American Academy of Ophthalmology
· Amgen Inc.
· Bausch & Lomb Incorporated
· Cipla Ltd.
· Clearside Biomedical, Inc.
· Enzo Biochem Inc.
· Eyegate Pharmaceuticals, Inc
· HanAll Biopharma
· Kiora Pharmaceuticals, Inc.
· L V PRASAD EYE INSTITUTE
· Lux Biosciences, Inc.
· Novartis AG
· Oculis SA
· Pfizer Inc.
· Regeneron Pharmaceuticals, Inc.
· Santen Pharmaceutical Co., Ltd.
· Sirion Therapeutics, Inc.
· Sun Pharmaceutical Industries Ltd.
· Tarsier Pharma Ltd
· Xoma CorporationFor more information about this report visit https://www.researchandmarkets.com/r/9l96fs

*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

*Attachment*

· Global Anterior Uveitis Treatment Market

CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900